Aparna Pharmaceuticals Private Limited - Company Profile

It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Aparna Pharmaceuticals Private Limited

Aparna Pharmaceuticals Private Limited, a active private limited company, was established on 01 September 2020 in Hyderabad, Telangana, India. Engaging in colorants within the hospital and medical care sector, it holds CIN: U24304TG2020PTC143375. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹881.00 Cr and a paid-up capital of ₹449.41 Cr.

It upholds a compliant status. Its leadership includes Pochana Aswin Reddy (Director), Sannareddy Aparna Reddy (Director), Rakesh Reddy Chennuru (Director). Past directors included Zia Ansari, Subbaraju Gokaraju, Yoganandavenkata Somayajulu Nuthi Subrahamanya. It holds ₹99.36 Cr open charges and ₹2.44 Cr settled loans. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at 802, D No 6-3-352/2 Road No 1, Banjara Hills, Hyderabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TG2020PTC143375

  • Registration Number

    143375

  • Incorporation Date

    01 September 2020

  • Authorized Capital

    ₹881.00 Cr

  • Paid-Up Capital

    ₹449.41 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 881.00 Cr
  • Paid Up Capital ₹ 449.41 Cr
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 99.36 Cr
  • Satisfied Charges ₹ 2.44 Cr
  • Revenue Growth **** 121.37%
  • Profit Growth **** -4545.03%
  • Ebitda **** -2793.83%
  • Net Worth -46.46%
  • Total Assets **** 1.28%
Company report

Aparna Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aparna Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aparna Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pochana Aswin Reddy Director 01 Sep 2020 Current
Sannareddy Aparna Reddy Director 01 Sep 2020 Current
Rakesh Reddy Chennuru Director 01 Sep 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Feb 2021 Past
Pramod Abcsdd Managing Director 20 Feb 2021 Past
Pramod Abcsdd Director 20 Feb 2021 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aparna Pharmaceuticals.

Aparna Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 121.37% increase. The company also saw a substantial fall in profitability, with a 4545.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.46%.

Aparna Pharmaceuticals revenue growth over time
Aparna Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 121.37%
*******
*******
*******
*******
Revenue from Operations
*******
 119.29%
*******
*******
*******
*******
Total Assets
*******
 1.28%
*******
*******
*******
*******
Profit or Loss
*******
 -4545.03%
*******
*******
*******
*******
Net Worth
*******
 -46.46%
*******
*******
*******
*******
EBITDA
*******
 -2793.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aparna Pharmaceuticals?

In 2024, Aparna Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹993,558,892.00

Satisfied Charges

₹24,406,085.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 99.36 Cr
Latest Charge Details
Date Lender Amount Status
02 May 2024 Hdfc Bank Limited ₹21.68 Cr Open
12 Apr 2019 Hdfc Bank Limited ₹31.68 Cr Open
28 Feb 2019 Hdfc Bank Limited ₹46.00 Cr Open
30 Sep 2020 Others ₹2.44 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aparna Pharmaceuticals?

Aparna Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aparna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aparna Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aparna Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aparna Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Aparna Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Charges

    The activity A charge registered on 30 Sep 2020 via Charge ID 100406822 with Others was fully satisfied on 11 Mar 2025. was completed.

  • Director Appointment

    The activity Mangala Nageshwar Modhekar was appointed as a Company Secretary was appointed as a Company Secretary on 25 Jan 2025 & has been associated with this company since 1 year 7 days . was completed.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 31.68 Cr registered on 12 Apr 2019 with Charge ID 100257742 was modified on 15 Jun 2024. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 21.68 Cr with Charge ID 100926957 was registered on 02 May 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aparna Pharmaceuticals Private Limited?

The CIN of Aparna Pharmaceuticals Private Limited is U24304TG2020PTC143375.

Where is Aparna Pharmaceuticals Private Limited headquartered?

Aparna Pharmaceuticals Private Limited is headquartered at 802, D No 6-3-352/2 Road No 1, Banjara Hills, Hyderabad, Telangana, 500034.

When was Aparna Pharmaceuticals Private Limited incorporated?

Aparna Pharmaceuticals Private Limited was incorporated on 01 September 2020.

Who are the current directors of Aparna Pharmaceuticals Private Limited?

The current directors of Aparna Pharmaceuticals Private Limited are

What is the primary industry of Aparna Pharmaceuticals Private Limited?

The primary industry of Aparna Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Aparna Pharmaceuticals Private Limited a listed company?

Aparna Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aparna Pharmaceuticals Private Limited?

The authorized capital of Aparna Pharmaceuticals Private Limited is ₹881.00 Cr, and the paid-up capital is ₹449.41 Cr.

What is the compliance status of Aparna Pharmaceuticals Private Limited?

The compliance status of Aparna Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available